Skip to content
  • Report Harm
  • Receive Newsletter
  • Press Room
Facebook Linkedin YouTube Instagram X Spotify
Benzodiazepine Information Coalition
  • About BenzodiazepinesExpand
    • Benzo BasicsExpand
      • Ashton Manual
      • A Brief History Of Benzodiazepines
      • Class Actions, Lawsuits and Reporting Harm 
      • FDA 2020 Benzodiazepine Boxed Warning
      • Medications and Supplements of Concern
      • Sleeping Pills: What You Need to Know
      • Xanax Study Outcomes
    • PrescribingExpand
      • Addiction vs Physical Dependence
      • Genetic Testing
      • Informed Consent
      • Low Dose Benzodiazepines
      • Mechanism of Action
      • Prescribing Statistics
      • Steps to Reduce Benzodiazepine Overprescribing
      • Therapeutic Actions
    • Prescribing RisksExpand
      • Akathisia
      • Fluoroquinolones
      • Functional Brain Changes
      • Interdose Withdrawal
      • Paradoxical Reactions
      • Physical Dependence
      • Risks of Remaining on Benzodiazepines
      • Red Flags
      • Short-Term Risks
      • Side Effects
      • Suicide
      • Tolerance
    • DeprescribingExpand
      • Ashton Manual
      • Detox, Cold Turkey, Abrupt Cessation
      • Dosages Prevent Safe Withdrawal
      • Estimates of Withdrawal
      • The Maudsley Deprescribing Guidelines
      • How To Find Tapering Help
      • Phenobarbital
      • Tapering Strategies and Solutions
    • Desprescribing RisksExpand
      • Akathisia
      • Benzodiazepine Withdrawal Syndrome (BWS)
      • Forced Switching or Stopping
      • Functional Brain Changes
      • Kindling
      • Protracted Withdrawal Syndrome (PWS)
      • Suicide
      • Withdrawal & Post Withdrawal Symptoms
    • Special PopulationsExpand
      • Benzodiazepines and PTSD
      • Celebrities
      • Benzodiazepines and COVID-19
      • Older Adults
      • Women
      • Incarcerated Population
      • Substance Use Disorders
  • About UsExpand
    • Our Mission
    • Board Members and Advisors
    • Press Room
    • Receive Our Newsletter
    • FAQs
    • Volunteer
  • Our ImpactExpand
    • Media Outreach
    • Press Room
    • Programs
    • Research and Publications
    • Past Speaking and Events
    • Upcoming Events
  • ResourcesExpand
    • Find Support
    • Benzodiazepine Cooperative Providers
    • Information
  • Contact Us
  • Blog
  • Donate
Donate
Facebook Linkedin X Instagram YouTube Spotify
Benzodiazepine Information Coalition

Risks of Remaining on Benzodiazepines

What are the risks of remaining on benzodiazepines long term?

Any patient already physically dependent on prescribed benzodiazepines should be the sole authority on whether they will remain on the medication or not. Forcing patients against their will to come off benzodiazepines is dangerous and often has poor outcomes. There are some populations too that may be too fragile or sick, find a great benefit to taking the medications, have a shortened lifespan, or respond so poorly to micro-reductions that they are unable to undertake a withdrawal program. These patients should be allowed the autonomy to remain on the medications and even have them increased as needed should they reach tolerance to the drugs.

Recognizing full patient autonomy, there are still major risks staying on benzodiazepines long term (longer than 2-4 weeks) that all patients should be informed of. These risks should be provided so that each patient may give fully informed consent. Only then will each patient be able to weigh these risks based on their own situation and should be free to make the decision as to whether to continue or to attempt a slow, controlled taper off. Some of the risks of continuing to take benzodiazepines long term are detailed below.

Results of a study in the UK by Dr. Heather Ashton which details the morbidity due to long-term prescription of benzodiazepines in 50 patients she saw in her benzodiazepine withdrawal clinic.

Risks:

  • Development of Tolerance and Tolerance Withdrawal
  • Increased risk of over-sedation
  • Adverse effects in pregnancy, including miscarraige, should the patient be of child-bearing age
  • Risk for developing paradoxical effects
  • Risks of endocrine effects: increased cortisol, prolactin, growth hormone secretion causing menstrual irregularities, pre-menstrual tension, breast engorgement, gynecomastia, and galactorrhoea
  • Increased risk of possible neurotoxic effects
  • Increased risk of polypharmacy
  • Increased risk of death when benzodiazepines are combined with some medications
  • Physical Dependence
  • Delaying the inevitable, that benzodiazepine cessation may be found to be either necessary or even forced later 
  • Increased risk of high medical costs due to benzodiazepines being responsible for frequent emergency and medical visits
  • Increased risk of misdiagnosis (from symptoms that are caused by benzodiazepines, but not attributed to them)
  • Exacerbation of the original condition (long-term benzodiazepine prescription worsens anxiety/depression/insomnia/PTSD, etc.)
  • Increased risk for developing new psychiatric problems (e.g. agoraphobia, panic, terror, fear, obsessions, and compulsions, etc.)
  • Increased risk of dose-escalation (due to tolerance to the original doses) or the addition of a second benzodiazepine and/or Z-drug
  • Increased risk of respiratory complications in the elderly
  • Possible increased risk of cancer
  • Increased risk of developing cognitive impairment
  • Possible increased risk of dementia and Alzheimer’s
  • Increased risk of falls and accidents
  • Increased risk of car accidents in the elderly
  • Increased risk of hip fracture and femur fracture
  • Increased risk of memory loss (which may or may not be permanent)
  • Losing relationships/jobs due to personality & emotional changes/ poor function
  • Increased risk of suicidality and depression
  • Increased risk of homicidal behavior
  • Increased risk for dangerous or disinhibited behavior
  • Increased risk of muscle wasting/loss of muscle mass
  • Increased risk for emotional blunting/apathy/anhedonia
  • Increased risk for sleep disturbances (which can cause long-term poor health)
  • Increased risk of death
  • Increased risk of sickness (e.g. flu) due to lowered immune response from benzodiazepine use
  • Increased risk of accidental overdose, especially in elderly, or with opioid users 
  • Increased risk of stroke and pneumonia in Alzheimer’s patients
  • Increased risk of GI disturbances

Newsletter

Get notified about the latest studies, updates, calls to action, media opportunities, and more!

Support BIC

Join us in making a difference today by supporting BIC with a tax-deductible donation.

Donate

Notices

Benzodiazepine Information Coalition is a 501(c)3 tax exempt organization.

EIN: 81-3442343

Medical Disclaimer
Online Interaction Policy
Privacy Policy

Facebook Linkedin YouTube Instagram Twitter Spotify

© 2025 Benzodiazepine Information Coalition

Scroll to top
  • About Benzodiazepines
    • Benzo Basics
      • Ashton Manual
      • A Brief History Of Benzodiazepines
      • Class Actions, Lawsuits and Reporting Harm 
      • FDA 2020 Benzodiazepine Boxed Warning
      • Medications and Supplements of Concern
      • Sleeping Pills: What You Need to Know
      • Xanax Study Outcomes
    • Prescribing
      • Addiction vs Physical Dependence
      • Genetic Testing
      • Informed Consent
      • Low Dose Benzodiazepines
      • Mechanism of Action
      • Prescribing Statistics
      • Steps to Reduce Benzodiazepine Overprescribing
      • Therapeutic Actions
    • Prescribing Risks
      • Akathisia
      • Fluoroquinolones
      • Functional Brain Changes
      • Interdose Withdrawal
      • Paradoxical Reactions
      • Physical Dependence
      • Risks of Remaining on Benzodiazepines
      • Red Flags
      • Short-Term Risks
      • Side Effects
      • Suicide
      • Tolerance
    • Deprescribing
      • Ashton Manual
      • Detox, Cold Turkey, Abrupt Cessation
      • Dosages Prevent Safe Withdrawal
      • Estimates of Withdrawal
      • The Maudsley Deprescribing Guidelines
      • How To Find Tapering Help
      • Phenobarbital
      • Tapering Strategies and Solutions
    • Desprescribing Risks
      • Akathisia
      • Benzodiazepine Withdrawal Syndrome (BWS)
      • Forced Switching or Stopping
      • Functional Brain Changes
      • Kindling
      • Protracted Withdrawal Syndrome (PWS)
      • Suicide
      • Withdrawal & Post Withdrawal Symptoms
    • Special Populations
      • Benzodiazepines and PTSD
      • Celebrities
      • Benzodiazepines and COVID-19
      • Older Adults
      • Women
      • Incarcerated Population
      • Substance Use Disorders
  • About Us
    • Our Mission
    • Board Members and Advisors
    • Press Room
    • Receive Our Newsletter
    • FAQs
    • Volunteer
  • Our Impact
    • Media Outreach
    • Press Room
    • Programs
    • Research and Publications
    • Past Speaking and Events
    • Upcoming Events
  • Resources
    • Find Support
    • Benzodiazepine Cooperative Providers
    • Information
  • Contact Us
  • Blog
  • Donate
Search